Pulmonal sarcoidosis: A rare side effect o interferon-α treatment for chronic hepatitis C infection;Pulmonale saikoidose: Eine seltene Nebenwirkung einer Interferon-α-therapie bei chronischer hepatitis-C-infektion

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 12, 2000, Pages 951-955

  Pohl, J ^a   Stremmel, W ^a   Kallinowski, B ^a  

^a Medizinische Klinik und Poliklinik V   (Germany)

Author keywords

Hepatitis C infection; Interferon ; Sarcoidosis

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CELLULAR IMMUNITY; COUGHING; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FEMALE; FLU LIKE SYNDROME; HEPATITIS C; HUMAN; MACROPHAGE; RADIOGRAPHY; RELAPSE; SARCOIDOSIS; T LYMPHOCYTE; BIOPSY; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DRUG COMBINATION; LUNG; PATHOLOGY; RISK FACTOR;

ADULT; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LUNG; RIBAVIRIN; RISK FACTORS; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034352298     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-10023     Document Type: Article

References (28)

1. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis
2. Role of IL-4 and IFN-γ in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function
3. Interferon-α und Ribavirin: Fortschritte in der Therapie der chronischen Hepatitis C
4. Combination therapy for hepatitis C infection
5. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
6. Interleukin-2 production by T cells: A study of the immunoregulatory actions of interferon-α, interferon-γ, and tumor necrosis factor-α in phenotypically different T cell clones
7. Natural human interferon-ι augments interleukin-2 production by a direct action on the activated IL-2-producing T cell
8. The immunomodulatory role of IFN-α or maltose-stabilized IFN-α on T-cell activation
9. Sarcoidosis associated with interferon-α therapy for chronic hepatitis C
10. Sarcoidosis after interferon therapy chronic active hepatitis C
11. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma
12. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C
13. Interferon-α therapy associated with the development of sarcoidosis
14. Sarcoid hypodermic nodules during chronic hepatitis C treated with interferon alpha 2b
15. Sarkoidose bei interferon-alpha-therapie
16. Cutaneous sarcoidosis in a patient with philadelphia-positive chronic myelogenous leukemia treated with interferon-α
17. Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia
18. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes
19. Interstitial pneumonitis and interferon-alpha
20. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis
21. INF-alpha inhibits antigen induced eosinophil and CD4+ T cell recruitment into tissue
22. Effects of interferon-α on cytokine profile. T cell receptor repertoire and peptide reactivity of human allergen-specific T cells
23. Activated T-cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
24. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis
25. Guess wharl cutaneous sarcoidosis. Sjorgen's syndrome and autoimmune thyreoditis associated with hepatitis C virus infection
26. Improvement of sarcoidosis under therapy with interferon-α 2b for chronic hepatitis B virus infection
27. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon